CD69: from activation marker to metabolic gatekeeper
Instituto de Salud Carlos III · Spanish National Centre for Cardiovascular Research · +4 more institutions
Abstract
CD69 is a membrane-bound, type II C-lectin receptor. It is a classical early marker of lymphocyte activation due to its rapid appearance on the surface of the plasma membrane after stimulation. CD69 is expressed by several subsets of tissue resident immune cells, including resident memory T (TRM) cells and gamma delta (γδ) T cells, and is therefore considered a marker of tissue retention. Recent evidence has revealed that CD69 regulates some specific functions of selected T-cell subsets, determining the migration-retention ratio as well as the acquisition of effector or regulatory phenotypes. Specifically, CD69 regulates the differentiation of regulatory T (Treg) cells as well as the secretion of IFN-γ, IL-17,…
Citation impact
- FWCI
- 17.27
- Percentile
- 100%
- References
- 64
Authors
2- DCDanay Cibrián
Instituto de Salud Carlos III, Spanish National Centre for Cardiovascular Research, Centro de Investigación Biomédica en Red, Spanish National Centre for Cardiovascular Research, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid
- FSFrancisco Sánchez‐MadridCorresponding
Instituto de Salud Carlos III, Spanish National Centre for Cardiovascular Research, Centro de Investigación Biomédica en Red, Spanish National Centre for Cardiovascular Research, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid
Topics & keywords
- Biology
- CD69
- Cell biology
- Immune system
- Effector
- Lectin
- Receptor
- T cell
Funding
- CDComunidad de MadridAward: INDISNET-S2011/BMD-2332
- FEFederación Española de Enfermedades Raras
- MDMinisterio de Economía y CompetitividadAwards: SAF2014-55579-R, SEV-2015-0505, S2011/BMD-2332, 20152330
- CNCentro Nacional de Investigaciones CardiovascularesAward: SEV-2015-0505
- MDMinisterio de Asuntos Económicos y Transformación Digital, Gobierno de EspañaAward: SEV-2015-0505
- CDCentro de Investigación Biomédica en Red Enfermedades Cardiovasculares
- EREuropean Research CouncilAward: ERC‐2011‐AdG294340‐GENTRIS
- IDInstituto de Salud Carlos IIIAwards: 20152330, SEV-2015-0505